Jiang YT, Zhang TY, Guo DD, Li R. An unusual huge thymoma composed of sclerosing thymoma and type AB thymoma: A case report.
Medicine (Baltimore) 2021;
100:e27873. [PMID:
34797329 PMCID:
PMC8601315 DOI:
10.1097/md.0000000000027873]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/11/2021] [Revised: 10/21/2021] [Accepted: 11/03/2021] [Indexed: 01/05/2023] Open
Abstract
RATIONALE
Sclerosing thymoma (ST) is quite a rare disease, as denoted in previous literature. Less than 20 cases of ST have been reported to date. However, the combined thymoma, composed of both type AB thymoma and ST, has never been described before.
PATIENT CONCERNS
The subject, a 49-year-old woman, came in with the chief complaint of cough for 10 days.
DIAGNOSES
Both the contrast-enhanced computed tomography scan and the ultrasonography showed a huge mass located in the right thoracic cavity with inhomogeneous contrast accompanied by the invasion of the pericardium and pleura. Subsequently, computed tomography-guided core-needle biopsy revealed type B2 thymoma, and type AB thymoma could not be excluded. Based on postsurgical histopathology and immunohistochemical finding, this tumor was given the final diagnosis of ST and type AB thymoma.
INTERVENTIONS
After 6 months of adjuvant chemotherapy and local radiotherapy, total thymectomy was performed.
OUTCOMES
The patient has been duly followed up for 1 year without any tumor recurrence.
LESSONS
ST is a very rare mediastinal neoplasm. Moreover, ST in combination with AB thymoma and affecting a large area, is unprecedented. Whether radiotherapy and chemotherapy have a certain effect on ST requires further investigation. In addition, due to the unclear recurrence rate of ST, long-term follow-up evaluation seems necessary.
Collapse